Dermapharm Holding SE (DMPHF PINK) stock market data APIs
$39.6493
0(0%)
as of May 13, 2025
Try our APIs with
free plan!
Dermapharm Holding SE Financial Data Overview
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Prev. Close
39.6493
Open
39.6493
High
39.6493
Low
39.6493
52 wk Range
39.56-42.684
Market Cap
2 368 M
P/E Ratio
16.692
Shares Outstanding
53 840 K
Revenue
1 195 M
Dividends (Yield)
0.0247
Beta
1.309
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Dermapharm Holding SE data using free add-ons & libraries
Get Dermapharm Holding SE Fundamental Data
Dermapharm Holding SE Fundamental data includes:
- Net Revenue: 1 195 M
- EBITDA: 251 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-13
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Dermapharm Holding SE News
New
Dermapharm Holding Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line
Dermapharm Holding (ETR:DMP) Full Year 2024 Results Key Financial Results Revenue: €1.20b (up 3.9% from FY 2023). Net income: €113.8m (up 82% from FY 2023). Profit margin: 9.5% (up from 5.4% in ...
Dermapharm Holding's (ETR:DMP) earnings trajectory could turn positive as the stock rises 8.9% this past week
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But in any portfolio, there are likely to be some stocks that fall shor...
Is Dermapharm Holding SE's (ETR:DMP) 15% ROE Better Than Average?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). By way of learnin...
Dermapharm Holding (ETR:DMP) stock falls 4.9% in past week as three-year earnings and shareholder returns continue downward trend
The truth is that if you invest for long enough, you're going to end up with some losing stocks. Long term Dermapharm Holding SE (ETR:DMP) shareholders know that all too well, since the share price is...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
